New data has shown prescriptions for attention deficit hyperactivity disorder are on the rise in Blackburn with Darwen, compared to other areas in the country.

According to the latest data from NHS Open Prescribing, attention deficit hyperactivity disorder (ADHD) prescriptions have increased in the borough.

ADHD is defined as a persistent pattern of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning.

Concerns have been raised that ADHD treatments are more readily given out in some areas, while others are left in need.

Figures show how many prescriptions were given out each month since 2019 in Blackburn with Darwen.

For the years of 2023 and 2022, 7,629 and 6,489 ADHD prescriptions were given out respectively in the borough.

For the years of 2021 and 2020, 5,867 and 5,323 respective prescriptions for the condition were given out.

In four years, the number of prescriptions rose by more than 2,300, an increase of 43 per cent.

From January to April this year, 2,644 prescriptions were given out for ADHD, compared to 2,335 in 2023 and 2,041 in 2022 in the same time periods a rise of 30 per cent since 2022.

Commonly taken ADHD drugs include methylphenidate (Ritalin), lisdexamfetamine (Elvanse) and dexamfetamine (Amfexa).

Just this week, an online test which could help diagnose children and young people with ADHD faster has been recommended for use on the NHS.

Known as the QbTest, the computer-based assessment tracks the movements of patients while measuring the three main symptoms of ADHD, which are inattention, impulsivity, and hyperactivity.

East Lancashire Hospitals NHS Trust has been contacted for comment.